Search

Your search keyword '"Li Liao"' showing total 1,709 results

Search Constraints

Start Over You searched for: Author "Li Liao" Remove constraint Author: "Li Liao"
1,709 results on '"Li Liao"'

Search Results

156. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus

160. Physical Properties Prediction Method and Application of Metamorphic Buried-hill Reservoirs based on Parameters of Mud Logging Engineering While Drilling.

163. Influence of Supervisor Leadership Style and Conflict Handling on Subordinates: A Case Study of Taoyuan Police Department

164. Effectiveness of Chinese Native Culture Education for Improving Undergraduate Nursing Students’ Transcultural Self-Efficacy

168. Hypertension Exacerbates Severity and Outcomes of COVID-19 in Elderly Patients: A Retrospective Observational Study

170. Targeting of plasmodesmal proteins requires unconventional signals

171. Avoiding Peer Information and Its Effects on Charity Crowdfunding: A Field Experiment

172. Reflections of High-Frequency Pulsed Ultrasound by Underwater Acoustic Metasurfaces Composed of Subwavelength Phase-Gradient Slits

174. Metal- and Pyrolysis-Free Ionic Covalent Organic Framework Nanosheet for Efficient Oxygen Evolution Reaction

177. Supplementary Figure 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

178. Supplementary Fig 3 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

179. Supplementary Fig 2 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

180. Supplementary Figure 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

181. Data from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

182. Supplementary Fig 5 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

183. Supplementary Figure 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

184. Supplementary Table 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

185. Supplementary Table 1 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

186. Supplementary Fig 6 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

187. Supplementary Figure 4 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

188. Supplementary Fig 4 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

189. Supplementary Table 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

190. Supplementary Table 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

191. Data from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

192. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates

194. Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

196. Immune Response Studies Based on P2X7 Receptors: A Mini-Review

197. Strategies of Prevascularization in Tissue Engineering and Regeneration of Craniofacial Tissues

198. Research Progress of Quercetin Delivery Systems

200. Three-dimensional microporous and mesoporous covalent organic frameworks based on cubic building units

Catalog

Books, media, physical & digital resources